These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34779656)

  • 21. Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries.
    Kundi H; Valsdottir LR; Popma JJ; Cohen DJ; Strom JB; Pinto DS; Shen C; Yeh RW
    Circ Cardiovasc Qual Outcomes; 2018 Oct; 11(10):e005048. PubMed ID: 30354574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Practical Two-Stage Frailty Assessment for Older Adults Undergoing Aortic Valve Replacement.
    Hosler QP; Maltagliati AJ; Shi SM; Afilalo J; Popma JJ; Khabbaz KR; Laham RJ; Guibone K; Kim DH
    J Am Geriatr Soc; 2019 Oct; 67(10):2031-2037. PubMed ID: 31211413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-Year Outcomes of Transfemoral Transcatheter Aortic Valve Replacement or Surgical Aortic Valve Replacement in a Real World Population.
    Barbanti M; Tamburino C; D'Errigo P; Biancari F; Ranucci M; Rosato S; Santoro G; Fusco D; Seccareccia F;
    Circ Cardiovasc Interv; 2019 Jul; 12(7):e007825. PubMed ID: 31284737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study.
    Afilalo J; Lauck S; Kim DH; Lefèvre T; Piazza N; Lachapelle K; Martucci G; Lamy A; Labinaz M; Peterson MD; Arora RC; Noiseux N; Rassi A; Palacios IF; Généreux P; Lindman BR; Asgar AW; Kim CA; Trnkus A; Morais JA; Langlois Y; Rudski LG; Morin JF; Popma JJ; Webb JG; Perrault LP
    J Am Coll Cardiol; 2017 Aug; 70(6):689-700. PubMed ID: 28693934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frailty and Bleeding in Older Adults Undergoing TAVR or SAVR: Insights From the FRAILTY-AVR Study.
    Bendayan M; Messas N; Perrault LP; Asgar AW; Lauck S; Kim DH; Arora RC; Langlois Y; Piazza N; Martucci G; Lefèvre T; Noiseux N; Lamy A; Peterson MD; Labinaz M; Popma JJ; Webb JG; Afilalo J
    JACC Cardiovasc Interv; 2020 May; 13(9):1058-1068. PubMed ID: 32381184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contemporary Trends and Outcomes of Percutaneous and Surgical Aortic Valve Replacement in Patients With Cancer.
    Guha A; Dey AK; Arora S; Cavender MA; Vavalle JP; Sabik JF; Jimenez E; Jneid H; Addison D
    J Am Heart Assoc; 2020 Jan; 9(2):e014248. PubMed ID: 31960751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.
    Garcia S; Kelly R; Mbai M; Gurevich S; Oestreich B; Yannopoulos D; Adabag S
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):390-398. PubMed ID: 29316204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.
    Reardon MJ; Heijmen RH; Van Mieghem NM; Williams MR; Yakubov SJ; Watson D; Kleiman NS; Conte J; Chawla A; Hockmuth D; Petrossian G; Robinson N; Kappetein AP; Li S; Popma JJ
    JAMA Cardiol; 2019 Aug; 4(8):810-814. PubMed ID: 31215985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Aortic Stenosis in Patients With End-Stage Renal Disease on Hemodialysis.
    Mentias A; Desai MY; Saad M; Horwitz PA; Rossen JD; Panaich S; Jneid H; Kapadia S; Vaughan-Sarrazin M
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e009252. PubMed ID: 32772570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comparative Study of TAVR versus SAVR in Moderate and High-Risk Surgical Patients: Hospital Outcome and Midterm Results.
    Abdelgawad AME; Hussein MA; Naeim H; Abuelatta R; Alghamdy S
    Heart Surg Forum; 2019 Aug; 22(5):E331-E339. PubMed ID: 31596707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcatheter aortic valve replacement versus surgical aortic valve replacement in low-surgical-risk patients: An updated meta-analysis.
    Goel S; Pasam RT; Wats K; Patel J; Chava S; Gotesman J; Malik BA; Frankel R; Shani J; Gidwani U
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):169-178. PubMed ID: 31631514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost and contribution margin of transcatheter versus surgical aortic valve replacement.
    McCarthy FH; Savino DC; Brown CR; Bavaria JE; Kini V; Spragan DD; Dibble TR; Herrmann HC; Anwaruddin S; Giri J; Szeto WY; Groeneveld PW; Desai ND
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):1872-1880.e1. PubMed ID: 28712581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing Wait-Time Mortality for Severe Aortic Stenosis: A Population-Level Study of the Transition in Practice From Surgical Aortic Valve Replacement to Transcatheter Aortic Valve Replacement.
    Albassam O; Henning KA; Qiu F; Cram P; Sheth TN; Ko DT; Woodward G; Austin PC; Wijeysundera HC
    Circ Cardiovasc Interv; 2020 Nov; 13(11):e009297. PubMed ID: 33167700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement.
    Pineda AM; Kevin Harrison J; Kleiman NS; Reardon MJ; Conte JV; O'Hair DP; Chetcuti SJ; Huang J; Yakubov SJ; Popma JJ; Beohar N
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):740-748. PubMed ID: 30341970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Length of Stay and Discharge Disposition After Transcatheter Versus Surgical Aortic Valve Replacement in the United States.
    Arora S; Strassle PD; Kolte D; Ramm CJ; Falk K; Jack G; Caranasos TG; Cavender MA; Rossi JS; Vavalle JP
    Circ Cardiovasc Interv; 2018 Sep; 11(9):e006929. PubMed ID: 30354596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.
    Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Days at home after transcatheter or surgical aortic valve replacement in high-risk patients.
    Chung M; Butala NM; Faridi KF; Almarzooq ZI; Liu D; Xu J; Song Y; Baron SJ; Shen C; Kazi DS; Yeh RW
    Am Heart J; 2023 Jan; 255():125-136. PubMed ID: 36309128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Episode Payments for Transcatheter and Surgical Aortic Valve Replacement.
    Modi PK; Sukul DA; Oerline M; Thompson MP; Nallamothu BK; Ellimoottil C; Shahinian VB; Hollenbeck BK
    Circ Cardiovasc Qual Outcomes; 2019 Dec; 12(12):e005781. PubMed ID: 31830824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.
    Kolte D; Vlahakes GJ; Palacios IF; Sakhuja R; Passeri JJ; Inglessis I; Elmariah S
    J Am Coll Cardiol; 2019 Sep; 74(12):1532-1540. PubMed ID: 31537261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States.
    Ando T; Akintoye E; Telila T; Briasoulis A; Takagi H; Schreiber T; Afonso L; Grines CL
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):813-819. PubMed ID: 28990736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.